What is the recommended intramuscular (IM) dose of Ativan (lorazepam) for seizure management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Intramuscular Lorazepam Dosing for Seizure Management

For seizure management, the recommended intramuscular (IM) dose of lorazepam is 0.05-0.1 mg/kg for adults, with a maximum of 4 mg per dose. 1

Adult Dosing

  • Standard IM lorazepam dosing for seizure activity in adults is 0.05-0.1 mg/kg per dose, which may be repeated if needed after 10-15 minutes 1
  • Maximum recommended dose is 4 mg per administration 2
  • Deep intramuscular injection technique is crucial for proper absorption and efficacy 1

Pediatric Dosing

  • For pediatric patients with seizures, the recommended IM lorazepam dose is 0.05-0.1 mg/kg (maximum 4 mg per dose) 2
  • For convulsive status epilepticus in children, lorazepam 0.1 mg/kg IV (maximum 2 mg) is recommended, which can be repeated once after at least 1 minute 3
  • For non-convulsive status epilepticus in children, a lower dose of 0.05 mg/kg IV (maximum 1 mg) is recommended 3

Special Population Considerations

  • Elderly patients require dose reduction due to decreased drug metabolism, with a recommended initial dose of 0.05 mg/kg 1
  • Patients with hepatic or renal impairment may require dose adjustments due to altered drug metabolism 1
  • Close monitoring is essential in patients taking other sedative medications due to potential additive effects 1

Administration and Monitoring

  • Monitor vital signs closely, particularly respiratory rate and oxygen saturation, due to risk of respiratory depression 1
  • Be prepared to provide respiratory support as lorazepam can cause apnea, especially when combined with other sedative agents 3, 2
  • Blood pressure monitoring is necessary due to risk of hypotension 1
  • Flumazenil should be available as a reversal agent for life-threatening respiratory depression, though it will also reverse the anticonvulsant effects 1, 2

Comparative Efficacy

  • Intramuscular midazolam has been shown to be at least as effective as intravenous lorazepam for pre-hospital seizure control 4
  • Intravenous lorazepam has demonstrated superior efficacy compared to intravenous diazepam or phenytoin for cessation of seizures 4
  • Lorazepam is particularly effective for generalized tonic-clonic status epilepticus but may be less effective for partial seizures with altered responsiveness 5

Common Pitfalls and Caveats

  • Respiratory depression is a significant risk, particularly in elderly patients and when combined with other sedative medications 1
  • Prolonged monitoring is essential, especially in elderly patients who may experience extended drug effects 1
  • Paradoxical reactions such as agitation can occasionally occur and should be monitored 1
  • Drug interactions are common, particularly with other CNS depressants, and may potentiate sedative effects 1

References

Guideline

Intramuscular Lorazepam Dosing for Seizure Activity in Elderly Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Lorazepam Administration in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Anticonvulsant therapy for status epilepticus.

The Cochrane database of systematic reviews, 2014

Research

Treatment of status epilepticus with lorazepam.

Archives of neurology, 1984

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.